Loading…
Polaryx Therapeutics, Inc. is projected to decline to $2.01 by 2027, a -13% move from its current price of $2.31. PLYX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $2.18 | $2.31 | $2.44 | -0.03% |
| Aug 5 | $2.13 | $2.31 | $2.50 | -0.05% |
| Aug 6 | $2.09 | $2.31 | $2.54 | -0.08% |
| Aug 7 | $2.06 | $2.31 | $2.58 | -0.11% |
| Aug 8 | $2.04 | $2.31 | $2.61 | -0.13% |
| Aug 9 | $2.01 | $2.31 | $2.65 | -0.16% |
| Aug 10 | $1.99 | $2.31 | $2.67 | -0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.99 | $2.31 | $2.67 | -0.18% |
| Week 2 | $1.87 | $2.30 | $2.84 | -0.37% |
| Week 3 | $1.78 | $2.30 | $2.97 | -0.55% |
| Week 4 | $1.71 | $2.29 | $3.08 | -0.74% |
| Week 5 | $1.64 | $2.29 | $3.19 | -0.92% |
| Week 6 | $1.59 | $2.28 | $3.28 | -1.10% |
| Week 7 | $1.54 | $2.28 | $3.37 | -1.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company focused on disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States.
Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.
Polaryx Therapeutics, Inc. trades under the symbol PLYX in the Healthcare sector. The current price is $2.31 and the company has a market capitalization of $109.36M, with a rank of 4107.
The forecast presents a range of possible prices across years. For 2026, the min is $1.96, the avg is $2.31, and the max is $3.18. The horizon shows higher upside in later years, with 2031 avg $2.63 and max $5.54, 2040 avg $3.50 and max $8.06, and 2050 avg $5.18 and max $11.90.
Overall price outlook from the forecast indicates potential long‑term upside, with bullish sentiment in 2040 and 2050 and ROIs of 51.7% and 124%, respectively. This contrasts with near-term neutrality to bearish signals in earlier years.
A major floor 34.6% below — a decisive break under it would weaken the trend.
The nearest floor, 15.2% below — buyers have tended to step in here.
The nearest ceiling, 21.6% above — a clean break opens room to run.
A major ceiling 237.2% above — clearing it would confirm fresh momentum.
Key PLYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.08 | Buy | $2.15 | Buy |
| MA 10 | $2.14 | Buy | $2.16 | Buy |
| MA 20 | $2.27 | Buy | $2.25 | Buy |
| MA 50 | $2.48 | Sell | $2.89 | Sell |
| MA 100 | $3.91 | Sell | $5.89 | Sell |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.13 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 19.93 | Neutral |
| Williams %R (14) | -22.22 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -4.15 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 77.78 | Neutral |
| TRIX (15) | -0.79 | Sell |
| Awesome (5,34) | -0.26 | Sell |
| Ultimate (7,14,28) | 54.28 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 2.11 | Buy |
| ADX (14) | 19.75 | Neutral |
| ATR (14) | 0.10 | Info |
The 30-day technical picture is NEUTRAL at present. RSI14 is 50, indicating a balanced momentum stance.
The 50-day simple moving average is $2.48, with a defined support level at $1.96 and a resistance level at $2.81. The 30-day trading range spans from a low of $1.60 to a high of $3.34, reflecting moderate volatility around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.96 | $2.31 | $3.18 | 0% | Neutral | |
| $1.32 | $2.01 | $3.30 | -13% | Neutral | |
| $1.14 | $1.93 | $3.45 | -17% | Bearish | |
| $0.8994 | $1.67 | $3.19 | -28% | Bearish | |
| $0.8563 | $1.73 | $3.49 | -25% | Bearish | |
| $1.19 | $2.63 | $5.54 | +14% | Neutral | |
| $1.17 | $2.60 | $5.69 | +12% | Neutral | |
| $1.08 | $2.41 | $5.47 | +4% | Neutral | |
| $1.18 | $2.63 | $6.05 | +14% | Neutral | |
| $0.975 | $2.17 | $4.98 | -6% | Neutral | |
| $1.58 | $3.51 | $8.07 | +52% | Bullish | |
| $2.33 | $5.17 | $11.90 | +124% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.96 | $2.31 | $2.82 | +0.00% |
| September 2026 | $1.71 | $2.14 | $2.84 | -7.21% |
| October 2026 | $1.76 | $2.26 | $3.07 | +5.21% |
| November 2026 | $1.77 | $2.31 | $3.22 | +2.51% |
| December 2026 | $1.69 | $2.23 | $3.18 | -3.36% |
Click any year to see its month-by-month PLYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect PLYX to range from $1.96 to $3.18 through 2026. The $2.31 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The PLYX price prediction for 2027 points to an average of $2.01 (low $1.32, high $3.30) — a potential decline of -13% on today's $2.31. A consolidation phase looks the most probable path here.
In 2028, PLYX is projected to trade between $1.14 and $3.45, averaging $1.93 — a potential decline of -17% from today's $2.31. That is -4% versus the projected 2027 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Polaryx Therapeutics, Inc.'s 2029 outlook centres on $1.67, within a $0.8994 to $3.19 range. That is -14% versus the projected 2028 average. That marks a -28% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2030, PLYX could reach as high as $3.49, with a base case around $1.73 and support toward $0.8563 — roughly -25% from $2.31. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect PLYX to range from $1.19 to $5.54 through 2031. The $2.63 average target implies a +14% move from current prices. That is up +52% on the projected 2030 average. A consolidation phase looks the most probable path here.
The PLYX price prediction for 2032 points to an average of $2.60 (low $1.17, high $5.69) — a potential gain of +12% on today's $2.31. Price action looks broadly range-bound.
In 2033, PLYX is projected to trade between $1.08 and $5.47, averaging $2.41 — a potential gain of +4% from today's $2.31. That is -7% versus the projected 2032 average. A consolidation phase looks the most probable path here.
Polaryx Therapeutics, Inc.'s 2034 outlook centres on $2.63, within a $1.18 to $6.05 range. That is up +9% on the projected 2033 average. That marks a +14% change versus current levels. Price action looks broadly range-bound.
By 2035, PLYX could reach as high as $4.98, with a base case around $2.17 and support toward $0.975 — roughly -6% from $2.31. A consolidation phase looks the most probable path here.
Expect PLYX to range from $1.58 to $8.07 through 2040. The $3.51 average target implies a +52% move from current prices. That is up +62% on the projected 2035 average. Momentum favours further upside here.
The PLYX price prediction for 2050 points to an average of $5.17 (low $2.33, high $11.90) — a potential gain of +124% on today's $2.31. Buyers look set to stay in control over this stretch.
Investing $1,000 in PLYX today (≈ 432.900433 PLYX) could be worth
$2,238.89
+$1,238.89 (+124%) by 2050 · US Dollar
Based on the average projected PLYX price of $5.17 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLYXwould be worth at today's price.
$1,000 invested in PLYX on Feb 2, 2026 (≈ 28.571429 PLYX) would be worth
$66
-$934 (-93.4%) today · 0.07× · US Dollar
Based on a PLYX entry price of $35 vs. today's $2.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.05 | $1,126.83 | +12.7% |
| 1 month ago | $2.58 | $895.35 | -10.5% |
| 3 months ago | $4.88 | $473.36 | -52.7% |
| 6 months ago | $35 | $66 | -93.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLYX forecast.
Our base-case forecast reaches $4.60 around 2050.
Implied market cap at $4.60: $217.78M
The multi-year forecast portrays a mixed path with notable upside potential in the longer term. The average price is $2.31 in 2026, then it declines to a low around $1.66-$1.74 through 2029–2030, before rising again to $2.63 by 2031 and extending higher through 2032–2035 (2032 $2.59, 2033 $2.41, 2034 $2.63, 2035 $2.16).
By 2040 the forecast shows an average price of $3.50 with a max of $8.06, and by 2050 an average of $5.18 with a max of $11.90. The forecast includes ROIs of 13.7% in 2031, 12.2% in 2032, 4.4% in 2033, 13.9% in 2034, and -6.3% in 2035, followed by strong upside of 51.7% in 2040 and 124% in 2050. Sentiment shifts from NEUTRAL in 2026–2035 to BULLISH in 2040 and 2050.
These are estimates, not guarantees, and actual results will vary with market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows min $0.8597, avg $1.74, max $3.51 with ROI -24.8% and sentiment BEARISH.
Forecasts show mixed signals: 2026 avg $2.31 with 0% ROI, then negative ROIs in 2027 (-13%), 2028 (-16.9%), 2029 (-28%), and 2030 (-24.8%), followed by positive ROIs from 2031 onward (e.g., 13.7% in 2031, 12.2% in 2032). The long-term outlook includes bullish years in 2040 (51.7% ROI) and 2050 (124% ROI). These are estimates, not guarantees.
Yes—the forecast’s 2050 max is $11.90, which means reaching $10 is within the projected upper bound by 2050, though it is not guaranteed.
The 30-day range is $1.60 to $3.34. RSI 14 is 50, SMA50 is $2.48. There is support at $1.96 and resistance at $2.81.
Current price is $2.31 and market capitalization is $109.36M.
Polaryx Therapeutics, Inc. Community Discussion
0Share your Polaryx Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.